The fragility of the U.S. vaccine supply

N Engl J Med. 2004 Dec 2;351(23):2443-7. doi: 10.1056/NEJMsb033394.
No abstract available

MeSH terms

  • Adult
  • Child
  • Costs and Cost Analysis
  • Drug Industry / economics*
  • Drug Industry / legislation & jurisprudence
  • Financing, Government*
  • Health Care Reform
  • Humans
  • Insurance Coverage
  • Insurance, Health
  • Liability, Legal
  • Quality Control
  • United States
  • Vaccines / economics
  • Vaccines / standards
  • Vaccines / supply & distribution*

Substances

  • Vaccines